BioLineRx, Gevys Pharmaceuticals Inc. deal

Gevys granted BioLineRx exclusive worldwide rights to develop and commercialize BL-3010 to treat acute and chronic pain. BioLineRx plans to start Phase I/II testing of the undisclosed compound within ...